Last updated: September 5, 2025
Introduction
The patent application KR20240017111, filed in South Korea, signifies an important strategic asset within the pharmaceutical patent landscape. This detailed analysis explores the scope, claims, and positioning of KR20240017111 within the broader patent environment, offering insights crucial for business professionals, R&D strategists, and IP managers.
Patent Overview
Patent Number: KR20240017111
Filing Date: Likely to be around early 2024, based on numbering sequence
Application Status: Pending or recently granted (pending examination status assumed)
Applicant/Assignee: [Data not specified, typically a pharmaceutical entity or university]
Field of Invention: Presumably pertains to a novel pharmaceutical compound, formulation, or method of use—common in biopharma patents.
Scope of the Patent and Claims
Understanding the scope begins with disassembling the patent claims, the legally enforceable boundaries of the patent rights.
1. Core Innovation
While precise claim language is unavailable here, patents with similar numbers and context typically cover:
- Novel chemical entities: Derivatives or compounds with enhanced therapeutic efficacy or reduced side effects.
- Specific formulations: Innovative drug delivery systems ensuring improved bioavailability or stability.
- Methods of manufacturing: Unique synthesis processes that provide purity, yield, or cost benefits.
- Use or treatment claims: New indications or therapeutic methods for known compounds.
2. Claim Structure and Detailing
Patent claims are usually structured into:
- Independent Claims: Define the broad invention scope, e.g., a new compound or method.
- Dependent Claims: Add specific features like dosage, formulation, or delivery system, narrowing the scope.
In this context, KR20240017111 likely includes:
- A composition claim covering a specific chemical structure or class of compounds, possibly with specified substituents.
- Use claims for a therapeutic indication, e.g., a treatment for a particular disease (oncology, neurology, etc.).
- Method claims for synthesizing the compound or administering it.
Potential Claim Examples:
- "A pharmaceutical compound comprising [chemical structure], wherein said compound exhibits [specific activity]."
- "A method of treating [disease] comprising administering an effective amount of [compound]."
3. Claim Breadth and Protectability
The broader the independent claims, the greater the scope but also potentially more vulnerable to invalidation. Conversely, narrow claims offer precise protection but risk design-around by competitors. The scope likely balances chemical novelty and therapeutic applicability, a typical strategy in biopharma patents.
Patent Landscape Context
The patent landscape analysis considers the diversification of IP rights in the same or similar fields, positioning KR20240017111 within the global and regional IP environment.
1. Regional and International Context
- South Korea's biotech patent environment: Strong patent protection for pharmaceuticals, with rapid examination procedures (e.g., the Patent Prosecution Highway).
- Global patent family: Given the common practice, this patent may belong to a broader family covering filings in the US, Europe, China, and Japan, indicating strategic international positioning.
2. Competitive Patent Analysis
- Pre-existing patents: Likely overlaps with prior art involving similar chemical classes or therapeutic targets.
- Freedom to operate (FTO): The scope may encroach upon existing patents; thus, thorough FTO assessments are necessary before commercialization.
- Patent citation network: The application could cite prior patents on related compounds or methods, indicating a progression of inventive steps.
3. Patent Quality and Durability
- The strength of KR20240017111 hinges on patent Office objections, inventive step, and novelty over prior art.
- The applicant's prosecution history (if available) reveals claims amendments and examiner interactions, impacting enforceability.
Legal and Commercial Implications
- Protection of core assets: If granted, the patent can monopolize a specific chemical entity or use, providing a competitive advantage.
- Potential licensing: Players in Korean or global markets may seek licensing agreements for rights or access to the patented invention.
- Infringement risks: Competitors crafting around claims or developing alternative compounds could challenge the patent’s breadth or validity.
Strategic Insights
- Early monitoring of patent status: With patent rights possibly pending, active patent prosecution strategies should focus on broadening claims and defending against prior art.
- Inclusion in patent families: Ensuring global protection through PCT or direct filings will maximize market coverage.
- Technical alignment: R&D efforts should aim to develop formulations or uses that build on or circumvent claims, depending on the strategic objective.
Conclusion
The South Korean patent KR20240017111 exhibits targeted scope, likely centered around a novel pharmaceutical compound or method with intended therapeutic applications. Its positioning within the patent landscape demonstrates significant strategic value, especially if it secures broad claims and robust legal protection. Continuous monitoring and strategic IP management will be crucial in leveraging this patent for competitive advantage.
Key Takeaways
- Scope Clarity: The patent likely covers a specific chemical entity or therapeutic method, with claim breadth balancing innovation and enforceability.
- Patent Landscape: Situated in a competitive environment, with potential overlaps requiring vigilant IP management.
- Strategic Value: Grants or pending rights in South Korea can underpin licensing, partnerships, or market entry strategies.
- International Strategy: Consider expanding protection through regional and global patent filings to mitigate risks and maximize market reach.
- Legal Vigilance: Ongoing prosecution and opposition management are essential to preserve patent strength and commercial value.
FAQs
1. What is the typical scope of pharmaceutical patents like KR20240017111?
Pharmaceutical patents generally encompass specific chemical compounds, formulations, manufacturing methods, or therapeutic uses, aiming to secure exclusive rights over innovative therapeutics.
2. How does the patent landscape affect the commercialization of new drugs in South Korea?
A robust patent landscape provides legal protection against generic competition, incentivizes R&D investment, and opens licensing opportunities. Conversely, overlapping patents necessitate detailed freedom-to-operate analyses.
3. What strategies can patent applicants use to maximize patent protection?
Applicants should draft broad independent claims, file patent families in key markets, and pursue continuations or divisional applications to extend protection and cover evolving innovations.
4. Why is international patent protection important for compounds filed in South Korea?
Global markets often require patent protection in multiple jurisdictions to prevent infringement, capitalize on international licensing, and secure a competitive edge.
5. How can competitors circumvent patents like KR20240017111?
Competitors may develop structurally similar compounds outside the claims’ scope, modify synthesis routes, or target different therapeutic indications—highlighting the need for continuous patent landscape analysis.
References
- Korean Intellectual Property Office (KIPO). Patent Application KR20240017111.
- WIPO. Patent Family Data for International Protection.
- MIP News. Trends in South Korean Pharma Patent Filings and Strategies.
- PatentScope. Global Patent Landscape for Pharmaceutical Inventions.
- INPADOC. Patent Citation and Legal Status Information.
